RU93046317A - Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции - Google Patents
Хиндроитиназа, способ ее получения и содержание ее фармацевтические композицииInfo
- Publication number
- RU93046317A RU93046317A RU93046317/14A RU93046317A RU93046317A RU 93046317 A RU93046317 A RU 93046317A RU 93046317/14 A RU93046317/14 A RU 93046317/14A RU 93046317 A RU93046317 A RU 93046317A RU 93046317 A RU93046317 A RU 93046317A
- Authority
- RU
- Russia
- Prior art keywords
- chondroitinase abc
- amino acid
- terminal amino
- chindroitinase
- contents
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000036765 Chondroitin-sulfate-ABC endolyases Human genes 0.000 claims 3
- 108090000819 Chondroitin-sulfate-ABC endolyases Proteins 0.000 claims 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 2
- 102100001249 ALB Human genes 0.000 claims 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 1
- OUCUOMVLTQBZCY-UHFFFAOYSA-N D-1-Amino-2-pyrrolidinecarboxylic acid Chemical compound NN1CCCC1C(O)=O OUCUOMVLTQBZCY-UHFFFAOYSA-N 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 1
- 108010071390 Serum Albumin Proteins 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 238000001962 electrophoresis Methods 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 238000005227 gel permeation chromatography Methods 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 230000000813 microbial Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002736 nonionic surfactant Substances 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 229920002401 polyacrylamide Polymers 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000012608 weak cation exchange resin Substances 0.000 claims 1
Claims (1)
- Кристаллизующаяся очищенная хондроитиназа ABC с молекулярной массой около 100000 получена методом электрофореза с использованием додецилсульфата натрия - полиакриламидного геля (SDS - PAGE) и методом гельпроникающей хроматографии содержит аланин в качестве N -концевой аминокислоты и пролин в качестве C - концевой аминокислоты. Способ очистки кристаллизующейся очищенной хондроитиназы ABC включает удаление нуклеиновой кислоты раствором поверхностно-активного вещества из экстракта, полученного из клеток микроорганизмов, продуцирующих хондроитиназу ABC, и хроматографирование при градиентном концентрированном элюировании с применением слабой катионо-обменной смолы или сильной катионо-обменной смолы. Композиция включает зондроитиназу и сывороточный альбумин, желатин или неионное поверхностно-активное вещество.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19288292 | 1992-06-26 | ||
JP192882/1992 | 1992-06-26 | ||
JP310980/1992 | 1992-10-26 | ||
JP31098092A JP3895782B2 (ja) | 1992-10-26 | 1992-10-26 | コンドロイチナーゼ組成物およびそれを含有する注射用製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93046317A true RU93046317A (ru) | 1996-05-20 |
RU2144833C1 RU2144833C1 (ru) | 2000-01-27 |
Family
ID=26507572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93046317A RU2144833C1 (ru) | 1992-06-26 | 1993-06-25 | Хондроитиназа, способ ее получения и включающие ее фармацевтические композиции |
Country Status (10)
Country | Link |
---|---|
US (3) | US5496718A (ru) |
EP (1) | EP0576294B1 (ru) |
KR (1) | KR100280779B1 (ru) |
AT (1) | ATE192486T1 (ru) |
CA (1) | CA2099138C (ru) |
DE (1) | DE69328519T2 (ru) |
DK (1) | DK0576294T3 (ru) |
ES (1) | ES2146600T3 (ru) |
RU (1) | RU2144833C1 (ru) |
SG (1) | SG50677A1 (ru) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5496718A (en) * | 1992-06-26 | 1996-03-05 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Chondroitinase ABC isolated from proteus vulgaris ATCC 6896 |
JP3419811B2 (ja) * | 1993-02-24 | 2003-06-23 | マルハ株式会社 | コンドロイチナーゼ遺伝子 |
US7008783B1 (en) | 1992-09-22 | 2006-03-07 | Maruha Corporation | Gene encoding chondroitinase ABC and uses therefor |
AU697156B2 (en) * | 1993-04-23 | 1998-10-01 | American Cyanamid Company | Cloning and expression of the chondroitinase I and II genes from (p. vulgaris) |
WO1995013091A1 (en) * | 1993-11-12 | 1995-05-18 | International Technology Management Associates, Ltd. | Methods of repairing connective tissues |
US5498536A (en) * | 1994-04-22 | 1996-03-12 | American Cyanamid Company | Chondroitinase II from Proteus vulgaris |
US5525500A (en) * | 1994-04-22 | 1996-06-11 | American Cyanamid Company | Chromatographic process for the copurification of chondroitinase I and II proteins from Proteus vulgaris |
EP0756636A4 (en) * | 1994-04-22 | 1997-12-17 | American Cyanamid Co | CHONDROITINASES I AND II, PROCESSES FOR THEIR PREPARATION AND THEIR USE |
US5888798A (en) * | 1995-06-07 | 1999-03-30 | American Cyanamid Company | Chondroitinase I and chondroitinase II producing mutants of P. vulgaris |
EP0747469A1 (en) | 1995-06-08 | 1996-12-11 | The Procter & Gamble Company | Cleaning compositions comprising chondroitinase |
EP0875253B1 (en) * | 1997-05-02 | 2005-04-06 | Seikagaku Corporation | Chondroitinase compositions |
JPH1149698A (ja) | 1997-07-31 | 1999-02-23 | Santen Pharmaceut Co Ltd | 安定性を向上させたラクトフェリンの水性製剤 |
US6063378A (en) * | 1997-08-22 | 2000-05-16 | Seikagaku Corporation | Therapeutic agent for herniated intervertebral disc |
ATE389414T1 (de) * | 1999-09-08 | 2008-04-15 | Chugai Pharmaceutical Co Ltd | Stabile proteinlösung abgefüllt in einem behältnis aus hydrophobem harz und eine methode zur stabilisierung derselben |
KR100520722B1 (ko) | 2001-06-01 | 2005-10-11 | 미쓰비시 세이시 가부시키가이샤 | 전(全)열교환 소자용지 |
CA2455827C (en) | 2001-08-13 | 2015-06-09 | University Of Florida Research Foundation, Inc. | Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan |
GB0205022D0 (en) | 2002-03-04 | 2002-04-17 | Univ Cambridge Tech | Materials and methods for the treatment of cns damage |
US8183350B2 (en) * | 2002-05-04 | 2012-05-22 | Acorda Therapeutics, Inc. | Compositions and methods for promoting neuronal outgrowth |
EP1532241B1 (en) * | 2002-06-03 | 2010-09-15 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from chondroitinase b |
US20060153827A1 (en) * | 2002-08-15 | 2006-07-13 | Gruskin Elliott A | Chimeric protein |
EP2298874A1 (en) * | 2002-12-16 | 2011-03-23 | Halozyme, Inc. | Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof |
US20090123367A1 (en) * | 2003-03-05 | 2009-05-14 | Delfmems | Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases |
US7871607B2 (en) * | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
US20060104968A1 (en) * | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
PL2405015T3 (pl) | 2003-03-05 | 2016-09-30 | Rozpuszczalna glikoproteina o aktywności hialuronizady (sHASEGP), sposób jej wytwarzania, jej zastosowania i zawierające ją kompozycje farmaceutyczne | |
US7959914B2 (en) | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
ES2373039T3 (es) * | 2003-05-16 | 2012-01-30 | Acorda Therapeutics, Inc. | Composiciones y métodos para el tratamiento de lesiones del cns. |
ES2636653T3 (es) | 2003-05-16 | 2017-10-06 | Acorda Therapeutics, Inc. | Mutantes degradantes del proteoglucano para el tratamiento del SNC |
GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
WO2005087920A2 (en) * | 2004-03-10 | 2005-09-22 | Massachusetts Institute Of Technology | Recombinant chondroitinase abc i and uses thereof |
WO2005112986A2 (en) * | 2004-05-18 | 2005-12-01 | Acorda Therapeutics, Inc. | Purifying chondroitinase and stable formulations thereof |
WO2005122734A2 (en) * | 2004-06-14 | 2005-12-29 | The Research Foundation Of State University Of New York | Nanosphere/microsphere delivery system for the treatment of spinal cord injury |
EP1848812A4 (en) * | 2004-10-01 | 2011-11-09 | Life Technologies Corp | SUPPLY BUFFERS, SYSTEMS AND METHODS FOR THE IN VITRO SYNTHESIS OF BIOMOLECULES |
WO2007038548A2 (en) | 2005-09-26 | 2007-04-05 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase abci mutants |
US8003369B2 (en) | 2005-11-29 | 2011-08-23 | Sanyo Chemical Industries, Ltd. | Bacteriolytic agent |
AU2007307736C1 (en) | 2006-10-10 | 2014-04-10 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase ABCI mutants |
JP5341756B2 (ja) | 2007-06-29 | 2013-11-13 | 国立大学法人名古屋大学 | 神経障害に基づく機能不全の改善剤およびRhoキナーゼ活性化抑制剤 |
US20090286289A1 (en) * | 2008-03-10 | 2009-11-19 | Pang Danny Z | Production of Hyaluronate Unsaturated Disaccharides and its Application |
RU2690185C2 (ru) * | 2010-12-13 | 2019-05-31 | Сейкагаку Корпорейшн | Терапевтическое средство от грыжи межпозвоночного диска |
ES2916834T3 (es) | 2014-09-27 | 2022-07-06 | Sumitomo Pharma Co Ltd | Composición farmacéutica para inyección |
US9796970B1 (en) | 2017-04-24 | 2017-10-24 | Advantek Serum Laboratories Ltd. | Production of high purity chondroitinase ABC |
CA3089180A1 (en) | 2018-02-28 | 2019-09-06 | Seikagaku Corporation | Pharmaceutical composition, package, and method for producing the same |
CN114409731B (zh) * | 2022-01-05 | 2023-08-11 | 浙江省农业科学院 | 同时具有激活乙醇脱氢酶和乙醛脱氢酶活性的两种多肽 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3549500A (en) * | 1967-07-22 | 1970-12-22 | Seikagaku Kogyo Co Ltd | Novel chondroitinase and method of its recovery |
JPS4832351B1 (ru) * | 1968-06-12 | 1973-10-05 | ||
JPS4713704Y1 (ru) * | 1971-09-29 | 1972-05-18 | ||
JPS6031479B2 (ja) * | 1978-02-10 | 1985-07-22 | 生化学工業株式会社 | 純コンドロイチナ−ゼcの製造法 |
JPS6031478B2 (ja) * | 1978-02-10 | 1985-07-22 | 生化学工業株式会社 | 純コンドロイチナ−ゼbの製造法 |
DK151634C (da) * | 1978-09-29 | 1988-06-20 | Mitsubishi Chem Ind | Fremgangsmaade til rensning af langkaedet acyl-coenzym-a-syntetase |
EP0139705A1 (en) * | 1983-04-21 | 1985-05-08 | La Trobe University | Enzyme extraction and purification processes |
US4696816A (en) * | 1985-11-07 | 1987-09-29 | Brown Mark D | Method for treating intervertebral disc displacement with enzymes |
JPS62122588A (ja) * | 1985-11-22 | 1987-06-03 | Taiyo Fishery Co Ltd | 純コンドロイチナ−ゼの製造法 |
JP2726275B2 (ja) * | 1988-08-24 | 1998-03-11 | 生化学工業株式会社 | グリコサミノグリカン分解酵素の精製法 |
JP2919496B2 (ja) * | 1989-08-24 | 1999-07-12 | 生化学工業株式会社 | 新規コンドロイチン硫酸分解酵素、それらを産生する微生物並びにそれらの製法 |
JP3140797B2 (ja) * | 1991-04-26 | 2001-03-05 | 生化学工業株式会社 | 安定化コンドロイチナーゼabc、その保存方法及び治療剤 |
US5496718A (en) * | 1992-06-26 | 1996-03-05 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Chondroitinase ABC isolated from proteus vulgaris ATCC 6896 |
-
1993
- 1993-06-23 US US08/082,853 patent/US5496718A/en not_active Expired - Lifetime
- 1993-06-25 SG SG1996008458A patent/SG50677A1/en unknown
- 1993-06-25 DE DE69328519T patent/DE69328519T2/de not_active Expired - Lifetime
- 1993-06-25 EP EP93304979A patent/EP0576294B1/en not_active Expired - Lifetime
- 1993-06-25 RU RU93046317A patent/RU2144833C1/ru active
- 1993-06-25 CA CA002099138A patent/CA2099138C/en not_active Expired - Lifetime
- 1993-06-25 AT AT93304979T patent/ATE192486T1/de active
- 1993-06-25 DK DK93304979T patent/DK0576294T3/da active
- 1993-06-25 ES ES93304979T patent/ES2146600T3/es not_active Expired - Lifetime
- 1993-06-25 KR KR1019930011667A patent/KR100280779B1/ko not_active IP Right Cessation
-
1995
- 1995-05-18 US US08/443,675 patent/US5763205A/en not_active Expired - Lifetime
-
1997
- 1997-07-07 US US08/888,530 patent/US6184023B1/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93046317A (ru) | Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции | |
CA2099138A1 (en) | Chondroitinase, Process for Preparing the Same, and Pharmaceutical Composition Comprising the Same | |
Dimuzio et al. | Phosphophoryns—major noncollagenous proteins of rat incisor dentin | |
Yonemasu et al. | Chemical studies on Clq; a modulator of immunoglobulin biology | |
Bellisario et al. | Human chorionic gonadotropin: linear amino acid sequence of the α subunit | |
Butkowski et al. | Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen. | |
Calvete et al. | A procedure for the large-scale isolation of major bovine seminal plasma proteins | |
Morris et al. | Characterization of monellin, a protein that tastes sweet | |
AU698334B2 (en) | Method for isolation of highly pure von willebrand factor | |
Bailey et al. | Partial characterization of a second basement membrane collagen in human placenta: evidence for the existence of two type IV collagen molecules | |
EP1111053A3 (fr) | Fragment peptidique de la protéine g du virus respiratoire syncytial, agent immunogène, composition pharmaceutique le contentant et procédé de préparation | |
CA2265935A1 (en) | Heat shock protein complexes | |
NZ509135A (en) | A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods | |
Bornstein | Comparative sequence studies of rat skin and tendon collagen. II. Absence of a short sequence at the amino terminus of the skin α1 chain | |
ES8702432A1 (es) | Procedimiento para la purificacion de una proteina | |
Joubert | Snake venom toxins: the amino acid sequences of two toxins from Ophiophagus hannah (King Cobra) venom | |
STOFFEL et al. | Cell-Free Translation of Human Liver Apolipoprotein AI and All mRNA Processing of Primary Translation Products | |
KR860004149A (ko) | 재조합 dna 기술에 의해 제조된 생리적 활성 물질의 정제방법 | |
PH24961A (en) | Monocional antibodies for human non-small cell lung carcinomas | |
Lopez et al. | The complete amino acid sequence of human complex-forming glycoprotein heterogeneous in charge (protein HC) | |
DK0419878T3 (da) | Nye aprotinin-varianter og genteknologisk fremgangsmåde til mikrobiel fremstilling af disse varianter i homogent processeret form | |
Sugiyama et al. | Isolation and characterization of histamine-releasing peptides from human parotid saliva | |
Takahashi et al. | Purification and characterization of anticomplement factor (cobra venom factor) from the Naja naja atra venom | |
YUMOTO et al. | Comparison of tryptic peptides from the heavy and light subunits of calpain I and calpain II by high performance liquid chromatography | |
DAHR et al. | Structural analysis of glycophorin A from Miltenberger class VIII erythrocytes |